Nationwide Trends of Severe Sepsis in the 21st Century (2000–2007)-Reference-Cited by-同舟云学术

Nationwide Trends of Severe Sepsis in the 21st Century (2000–2007)

Published:2011-11 Issue:5 Volume:140 Page:1223-1231
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Kumar Gagan,Kumar Nilay,Taneja Amit,Kaleekal Thomas,Tarima Sergey,McGinley Emily,Jimenez Edgar,Mohan Anand,Khan Rumi Ahmed,Whittle Jeff,Jacobs Elizabeth,Nanchal Rahul

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference29 articles.

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis;Bone;Chest,1992

2. Contribution of major diseases to disparities in mortality;Wong;N Engl J Med,2002

3. Efficacy and safety of recombinant human activated protein C for severe sepsis;Bernard;N Engl J Med,2001

4. Intensive insulin therapy in the critically ill patients;van den Berghe;N Engl J Med,2001

5. Hydrocortisone therapy for patients with septic shock;Sprung;N Engl J Med,2008

Cited by 506 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of Shenfu injection in septic patients with hypoperfusion: A multi-center, open-label, randomized, controlled trial;Journal of Intensive Medicine;2024-10

2. Mitochondrial function in lungs of rats with different susceptibilities to hyperoxia-induced acute lung injury;Journal of Applied Physiology;2024-08-01

3. Primary Infection Site as a Predictor of Sepsis Development in Emergency Department Patients;The Journal of Emergency Medicine;2024-08

4. Early high-sensitivity troponin elevation in predicting short-term mortality in sepsis: A protocol for a systematic review with meta-analysis;2024-03-29

5. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock;Trials;2024-03-12